glp 1 fda approval 💊New GLP-1 pill gets approval, and has fewer restrictions on how it's used💊 FDA-Approved Dosages and Indications for

The SELECT trial establishing semaglutides 20% reduction in major adverse cardiovascular events has converted GLP-1 receptor agonists from single-indication obesity drugs into foundational chronic disease therapeutics demanding continuous prescription renewal

Cunto tiempo antes de ver los efectos

It has to be mentioned that KO mice for IGF-1 gene are not viable and studies in such mice have to be done in the first days of life, and thus results are not very conclusive as metabolism is not properly established at this stage [129, 228]

Less frequent dosing (biweekly) is less effective for sustained energy improvement

Nardin RA, Johns DR: Mitochondrial dysfunction and neuromuscular disease

These second order effects will become more far reaching as insurance coverage becomes wider for these drugs - this will be the differentiator between the risk/reward being better on the first-order beneficiaries (LLY and NVO) and the second-order plays like short bariatric surgery/sleep apnea/gyms/fast food & CPG